Last update:
Immunology news
Immunology
Bacteria in the intestine that change in response to inflammation could have an impact on our immune system
Gut bacteria have emerged as a focal point of scientific exploration, with their intricate roles in our metabolism, nutrition, and overall health coming into sharp focus. New research from the Technion—Israel Institute ...
15 hours ago
0
71
Oncology & Cancer
Improving cancer immunotherapy by prolonging T-cell survival
In the past decade, immunotherapy has emerged as the fourth pillar of cancer treatment, joining surgery, radiotherapy and chemotherapy. It is an approved treatment for 15 cancers, including melanoma and some types of lymphomas ...
16 hours ago
0
43
Hitchhiking of synthetic antigen stimulates antibody production against cancer cells
Researchers at the Indian Institute of Science (IISc) have designed a synthetic compound (antigen) that can latch on to a protein in blood and hitchhike a ride to the lymph node, where it can boost the production of antibodies ...
21 hours ago
0
14
Genetically engineering a treatment for incurable brain tumors
Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional ...
21 hours ago
0
29
Researchers identify connection between air pollutants and allergic diseases
A study by researchers at National Jewish Health published in the Annals of Allergy, Asthma & Immunology reports that air pollutants—including particulate matter, pollen, greenhouse gases, and other harmful substances—can ...
15 hours ago
0
0
Review highlights the potential and promise of CAR-T cell therapy in autoimmune diseases
Autoimmune disease (AID) refers to the condition in which the immune system identifies the body's own cells and tissues as foreign, resulting in systemic inflammation. The immune system's self-attack via autoreactive B and ...
15 hours ago
0
2
Researchers develop a new way to safely boost immune cells to fight cancer
Last year alone, more than 600,000 people in the United States died from cancer, according to the American Cancer Society. The relentless pursuit of understanding this complex disease has shaped medical progress in developing ...
Apr 19, 2024
0
113
Signs of multiple sclerosis show up in blood years before symptoms, study finds
In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of some people who later went on to develop the disease.
Apr 19, 2024
0
61
Engineered peptides open new avenue for immunotherapy drug development
In a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have designed a new method for developing immunotherapy drugs using engineered peptides to elicit ...
Apr 19, 2024
0
72
Study of cancer-induced liver inflammation finds a promising therapeutic target
Liver inflammation, a common side-effect of cancers elsewhere in the body, has long been associated with worse cancer outcomes and more recently associated with poor response to immunotherapy. Now, a team led by researchers ...
Apr 19, 2024
0
34
A new therapeutic target for traumatic brain injury
For the roughly 1.5 million Americans per year who survive a traumatic brain injury, health outcomes vary widely. Not only can these injuries lead to a loss of coordination, depression, impulsivity, and difficulty concentrating, ...
Apr 19, 2024
0
10
Black women hospitalized in US with blood infection resistant to last-resort antibiotic at increased risk of death
New research being presented at this year's ESCIMD Global Congress (formerly ECCMID) in Barcelona, Spain (27–30 April), finds that the odds of death in Black women with a bloodstream infection (BSI) caused by carbapenem-resistant ...
Apr 19, 2024
0
0
New stem cell model can help personalize stem cell treatment for immunodeficiency patients
A collaborative research team has pioneered a new stem cell model to help personalize treatment for patients suffering from rare forms of immunodeficiency. The research findings were published in the Journal of Allergy and ...
Apr 19, 2024
0
0
Immune cells carry a long-lasting 'memory' of early-life pain
In recent years, a growing body of research has shown that the human body can "remember" the pain of newborn injuries—including life-saving surgeries—all the way into adolescence.
Apr 18, 2024
0
19
Long COVID patients show immunological improvement two years after infection
Biomarkers for long COVID that were present in patients at eight months have largely resolved by 24 months among a cohort of people who contracted COVID-19 during Australia's first wave.
Apr 18, 2024
0
33
Novel cell therapy treatments offer promise to immune-compromised children
In a first-of-its-kind clinical trial, researchers found that intravenous therapies made from virus-specific T-cells (VST) can effectively treat immunocompromised pediatric patients, far surpassing the current standard of ...
Apr 18, 2024
0
11
Researchers identify patterns that predict ovarian cancer relapse
Using spatial analysis of tissue samples, Cedars-Sinai investigators have identified patterns that could predict whether patients with the most common type of ovarian cancer will experience early relapse after treatment. ...
Apr 18, 2024
0
18
Study finds promising biomarker for cellular rejection after organ transplant
Today, patients who receive an organ transplant need repeated surgical biopsies to test for acute cellular rejection (ACR) throughout their lifetimes. But a blood test for ACR could be on the horizon following the discovery ...
Apr 18, 2024
0
1
COVID-19 booster immunity lasts much longer than primary series alone, study shows
Thinking about getting a spring-time booster shot? A new study coming out of York University's Centre for Disease Modelling in the Faculty of Science shows that immunity after a COVID-19 booster lasts much longer than the ...
Apr 18, 2024
0
72
Researchers discover new therapeutic target for non-small cell lung cancer
Non-small cell lung cancer accounts for nearly 85% of all lung cancer cases. Targeted immunotherapy is a common treatment, but it does not work for everyone. However, a new Moffitt Cancer Center study published in the journal ...
Apr 18, 2024
0
4
